BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36409492)

  • 1. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
    Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
    JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
    Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
    Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
    Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
    JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
    Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
    CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Ethnic Disparities in Lung Cancer Screening Eligibility.
    Narayan AK; Chowdhry DN; Fintelmann FJ; Little BP; Shepard JO; Flores EJ
    Radiology; 2021 Dec; 301(3):712-720. PubMed ID: 34546133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations.
    Reese TJ; Schlechter CR; Potter LN; Kawamoto K; Del Fiol G; Lam CY; Wetter DW
    JAMA Netw Open; 2021 Jan; 4(1):e2033769. PubMed ID: 33433600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung Cancer Screening in Brazil Comparing the 2013 and 2021 USPSTF Guidelines.
    Emmerick ICM; Campos MR; Castanheira D; Muzy J; Marques A; Arueira Chaves L; Sobreira da Silva MJ
    JAMA Netw Open; 2023 Dec; 6(12):e2346994. PubMed ID: 38079172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
    Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
    JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with low-dose CT lung cancer screening participation in a high burden state: Results from the 2017-2018 BRFSS.
    Sedani AE; Ford LA; James SA; Beebe LA
    J Cancer Policy; 2021 Jun; 28():100284. PubMed ID: 35559913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the lung cancer screening eligibility criteria to promote equity for Black individuals.
    Gudina AT; Kamen C; Hardy SJ; Kehoe L; Culakova E; Cupertino AP
    Lung Cancer; 2024 May; 191():107539. PubMed ID: 38552545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer screening eligibility and use with low-dose computed tomography: Results from the 2018 Behavioral Risk Factor Surveillance System cross-sectional survey.
    Narayan AK; Gupta Y; Little BP; Shepard JO; Flores EJ
    Cancer; 2021 Mar; 127(5):748-756. PubMed ID: 33206388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study.
    Silvestri GA; Goldman L; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Tanner NT; Fedewa S
    Ann Intern Med; 2022 Nov; 175(11):1501-1505. PubMed ID: 36215712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Eligibility for Lung Cancer Screening by Race After 2021 Changes to US Preventive Services Task Force Screening Guidelines.
    Pinheiro LC; Groner L; Soroka O; Prosper AE; Jack K; Tamimi RM; Safford M; Phillips E
    JAMA Netw Open; 2022 Sep; 5(9):e2229741. PubMed ID: 36053535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
    Toumazis I; de Nijs K; Cao P; Bastani M; Munshi V; Ten Haaf K; Jeon J; Gazelle GS; Feuer EJ; de Koning HJ; Meza R; Kong CY; Han SS; Plevritis SK
    JAMA Oncol; 2021 Dec; 7(12):1833-1842. PubMed ID: 34673885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Primary Care Physician Knowledge of Lung Cancer Screening Guidelines on Perceptions and Utilization of Low-Dose Computed Tomography.
    Raz DJ; Wu GX; Consunji M; Nelson RA; Kim H; Sun CL; Sun V; Kim JY
    Clin Lung Cancer; 2018 Jan; 19(1):51-57. PubMed ID: 28652090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating Eligibility for Lung Cancer Screening by Neighborhood in Philadelphia Using Previous and Current USPSTF Guidelines.
    McIntire RK; Lewis E; Zeigler-Johnson C; Shusted C; Barta J; Juon HS; Keith SW; Klein G
    Popul Health Manag; 2022 Apr; 25(2):254-263. PubMed ID: 35442796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation.
    Japuntich SJ; Krieger NH; Salvas AL; Carey MP
    J Natl Med Assoc; 2018 Oct; 110(5):424-427. PubMed ID: 30129479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
    Li J; Chung S; Wei EK; Luft HS
    BMC Health Serv Res; 2018 Jul; 18(1):525. PubMed ID: 29976189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.
    Luo YH; Luo L; Wampfler JA; Wang Y; Liu D; Chen YM; Adjei AA; Midthun DE; Yang P
    Lancet Oncol; 2019 Aug; 20(8):1098-1108. PubMed ID: 31255490
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.